Latest News & Features
Americas
The US Supreme Court yesterday denied a petition for certiorari in a case centring on Lamictal, a treatment for certain types of seizures as well as bipolar disorder. 8 November 2016
Big Pharma
To overcome a crowded patent market, a potential solution is to seek a declaration of obviousness, which has a basis in UK law stemming from Arrow Generics v Merck. Richard Roberts of Potter Clarkson reports. 8 November 2016
Americas
US-based Amarin Pharma has filed a complaint against Dr Reddy’s Laboratories for allegedly infringing 14 patents covering Vascepa. 7 November 2016
Big Pharma
The IP Life Sciences Exchange, an event for senior IP decision-makers from the life sciences sector, will take place on November 15 and 16 in Munich, Germany. LSIPR previews some of the most interesting sessions. 7 November 2016
Americas
GE Healthcare Life Sciences has revealed a $7 million expansion project at its technology manufacturing facility in Westborough, Massachusetts. 4 November 2016
Americas
The US Court of Appeals for the Second Circuit has affirmed a ruling of a district court in a trademark infringement dispute between Abbott Laboratories and pharmacies, distributors and individuals. 4 November 2016
Americas
A dietary supplement, MigreLief, is at the centre of a patent dispute between Akeso Health Sciences and Family Tree Remedies. 3 November 2016
Asia
India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million. 3 November 2016
Americas
US-based Onyx Therapeutics has filed a complaint against India company Dr Reddy’s Laboratories for allegedly infringing a patent covering the drug Kyprolis. 3 November 2016
Big Pharma
Stephen Dorrell, the former UK health minister, has warned in a report for Public Policy Projects that a “hard Brexit” deal could affect Britain’s access to new drugs. 3 November 2016